comparemela.com

Latest Breaking News On - Maxcyte company profile - Page 1 : comparemela.com

Maher Masoud Purchases 70,443 Shares of MaxCyte, Inc (NASDAQ:MXCT) Stock

MaxCyte, Inc. (NASDAQ:MXCT – Get Free Report) CEO Maher Masoud acquired 70,443 shares of the stock in a transaction dated Monday, June 10th. The stock was bought at an average cost of $4.90 per share, with a total value of $345,170.70. Following the completion of the purchase, the chief executive officer now owns 100,000 shares […]

5,644,898 Shares in MaxCyte, Inc (NASDAQ:MXCT) Acquired by Cadian Capital Management LP

Cadian Capital Management LP acquired a new position in MaxCyte, Inc. (NASDAQ:MXCT – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 5,644,898 shares of the company’s stock, valued at approximately $26,531,000. MaxCyte comprises about 1.1% of Cadian […]

MaxCyte (NASDAQ:MXCT) Sees Large Volume Increase

MaxCyte (NASDAQ:MXCT) Sees Large Volume Increase
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Valmark Advisers Inc Buys New Shares in MaxCyte, Inc (NASDAQ:MXCT)

Valmark Advisers Inc. bought a new stake in MaxCyte, Inc. (NASDAQ:MXCT – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 83,927 shares of the company’s stock, valued at approximately $394,000. Valmark Advisers Inc. owned about 0.08% of MaxCyte […]

MaxCyte s (MXCT) Overweight Rating Reiterated at Stephens

MaxCyte s (MXCT) Overweight Rating Reiterated at Stephens
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.